Summit Therapeutics Inc.

Q4 2020 13F Holders

Symbol
SMMT
CUSIP
86627T108
Type
Equity
Class
COM
Num filings
34
Total reported value, excl. options
$42.7 M
Manager Report Date Value ($000) Shares Option Type